Clinical case of lupus erythematosus panniculitis

N. P. Teplyuk , O. V. Grabovskaya , Polina A. Razhev

Russian Journal of Skin and Venereal Diseases ›› 2020, Vol. 23 ›› Issue (5) : 334 -340.

PDF
Russian Journal of Skin and Venereal Diseases ›› 2020, Vol. 23 ›› Issue (5) : 334 -340. DOI: 10.17816/dv60811
CLINICAL PICTURE, DIAGNOSIS, AND THERAPY OF DERMATOSES
review-article

Clinical case of lupus erythematosus panniculitis

Author information +
History +
PDF

Abstract

BACKGROUND: This clinical case is interesting because of extreme rarity of lupus panniculitis in the population, as well as the possible risk of developing systemic lupus erythematosus.

CASE REPORT: The article presents a clinical observation of a rare skin disorder – lupus erythematosus panniculitis and the results of a successful combined treatment of the disease with systemic glucocorticoids (prednisolone), and an antimalarial agent (hydroxychloroquine). A review of the literature on the etiology, pathogenesis, and diagnosis of lupus panniculitis has been conducted.

CONCLUSION. Early detection of lupus erythematosus panniculitis (LEP) makes systemic steroid therapy and quinoline drugs more effective in achieving remission. That is why dynamic monitoring of patients with LEP is important to identify new or progressive symptoms.

Keywords

lupus erythematosus panniculitis / lupus panniculitis / lupus profundus / Kaposi–Irgang / clinical case

Cite this article

Download citation ▾
N. P. Teplyuk, O. V. Grabovskaya, Polina A. Razhev. Clinical case of lupus erythematosus panniculitis. Russian Journal of Skin and Venereal Diseases, 2020, 23(5): 334-340 DOI:10.17816/dv60811

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Rangel LK, Villa-Ruiz C, Lo K, Cobos G, Lo Sicco K, Vleugels RA, Femia AN. Clinical characteristics of lupus erythematosus panniculitis / profundus: a retrospective review of 61 patients. JAMA Dermatol. 2020;156(11):1264-6. doi: 10.1001/jamadermatol.2020.2797.

[2]

Rangel L.K., Villa-Ruiz C., Lo K., Cobos G., Lo Sicco K., Vleugels R.A., Femia A.N. Clinical characteristics of lupus erythematosus panniculitis / profundus: a retrospective review of 61 patients. JAMA Dermatol. 2020;156(11):1264-6. doi: 10.1001/jamadermatol.2020.2797.

[3]

Braunstein I, Werth VP. Update on management of connective tissue panniculitis. Dermatol Ther. 2012;25(2):173-82. doi: 10.1111/j.1529-8019.2012.01489.x.

[4]

Braunstein I., Werth V.P. Update on management of connective tissue panniculitis. Dermatol Ther. 2012;25(2):173-82. doi: 10.1111/j.1529-8019.2012.01489.x.

[5]

Irgang S. Lupus erythematosus profundus: Report of an example with clinical resemblance to Darier-Roussy sarcoid. Arch Dermatol Syph. 1940;42:97-108.

[6]

Arnold HL. Lupus Erythematosus Profundus: Commentary and report of four more cases. AMA Arch Derm. 1956;73(1):15-33.

[7]

Arnold H.L. Lupus Erythematosus Profundus: Commentary and report of four more cases. AMA Arch Derm. 1956;73(1):15-33.

[8]

Narges Alizade, Rafi ei Rana, Mesbah Alireza, Naji Rad Sara. Lupus erythematosus panniculitis treated with stromal vascular fraction. J Am Acad Dermatol. 2017;76(6):163. doi: 10.1016/j.jaad.2017.04.634.

[9]

Reich A, Marcinow K, Bialynicki-Birula R. The lupus band test in systemic lupus erythematosus patients. Ther Clin Risk Manag. 2011;7:27-32. doi: 10.2147/TCRM.S10145.

[10]

Reich A., Marcinow K., Bialynicki-Birula R. The lupus band test in systemic lupus erythematosus patients. Ther Clin Risk Manag. 2011;7:27-32. doi: 10.2147/TCRM.S10145.

[11]

Peters MS, Su WP. Panniculitis. Dermatol Clin. 1992;10(1):37-57.

[12]

Peters M.S., Su W.P. Panniculitis. Dermatol Clin. 1992;10(1):37-57.

[13]

Winkelmann RK, Peters MS. Lupus panniculitis. In: Moschella SL, ed. Dermatology update. New York: Elsevier; 1982:135-52.

[14]

Winkelmann R.K., Peters M.S. Lupus panniculitis. In: Moschella S.L., ed. Dermatology update. New York: Elsevier; 1982:135-52.

[15]

Lupus panniculitis: Uncommon clinical presentations in patients with certain predisposing factors. J Am Acad Dermatol. 2019;81(4):235. doi: 10.1016/j.jaad.2019.06.1054.

[16]

Mangold AR, Costello CM, Cumsky HJL, DiCaudo DJ, Griffing WL, Pittelkow MR. Systemic scleroderma and lupus panniculitis with atypical clinical features: A case report and comprehensive review. JAAD Case Rep. 2018;4(8):789-93. doi: 10.1016/j.jdcr.2018.03.022.

[17]

Mangold A.R., Costello C.M., Cumsky H.J.L., DiCaudo D.J., Griffing W.L., Pittelkow M.R. Systemic scleroderma and lupus panniculitis with atypical clinical features: A case report and comprehensive review. JAAD Case Rep. 2018;4(8):789-93. doi: 10.1016/j.jdcr.2018.03.022.

[18]

Linear sclerodermoid lupus erythematosus panniculitis. J Am Acad Dermatol. 2015;72(5):200. doi: 10.1016/j.jaad.2015.02.812..

[19]

Linear sclerodermoid lupus erythematosus panniculitis. J Am Acad Dermatol. 2015;72(5):200. doi: 10.1016/j.jaad.2015.02.812.

[20]

Olisova OYu, Grabovskaya OV, Teplyuk NP, Belousova TA, Dzhavakhishvili IS, Varshavsky VA. Panniculitis caused by α1-antitrypsin deficiency. Russian Journal of Skin and Venereal Diseases. 2014;17(3):32-5. (in Russian)

[21]

Олисова О.Ю., Грабовская О.В., Теплюк Н.П., Белоусова Т.А., Джавахишвили И.С., Варшавский В.А. Панникулит, обусловленный дефицитом α1-антитрипсина // Российский журнал кожных и венерических болезней. 2014;17(3):32-5.

[22]

Correll CK, Miller DD, Maguiness SM. Treatment of Childhood-Onset Lupus Erythematosus Panniculitis With Rituximab. JAMA Dermatol. 2020;156(5):566-9. doi: 10.1001/jamadermatol. 2019.4984.

[23]

Correll C.K., Miller D.D., Maguiness S.M. Treatment of Childhood-Onset Lupus Erythematosus Panniculitis With Rituximab. JAMA Dermatol. 2020;156(5):566-9. doi: 10.1001/jamadermatol.2019.4984.

[24]

Shipman WD, Vernice NA, Demetres M, Jorizzo JL. An update on the use of hydroxychloroquine in cutaneous lupus erythematosus: A systematic review. J Am Acad Dermatol. 2020;82(3):709-22. doi: 10.1016/j.jaad.2019.07.027.

[25]

Shipman W.D., Vernice N.A., Demetres M., Jorizzo J.L. An update on the use of hydroxychloroquine in cutaneous lupus erythematosus: A systematic review. J Am Acad Dermatol. 2020;82(3):709-22. doi: 10.1016/j.jaad.2019.07.027.

[26]

Peters MS, Su WP. Lupus erythematosus panniculitis. Med Clin North Am. 1989;73(5):1113-26. doi: 10.1016/s0025-7125(16)30622-8.

[27]

Peters M.S., Su W.P. Lupus erythematosus panniculitis. Med Clin North Am. 1989;73(5):1113-26. doi: 10.1016/s0025-7125(16)30622-8.

[28]

Llamas-Velasco M, Ovejero-Merino E, Fraga J, García-Diez A, Moreno-Balsalobre R. Pemetrexed-induced painful erythematous nodules in both legs in a patient with recurrent mesothelioma. J Cutan Pathol. 2018;45(2):184-6. doi: 10.1111/cup.13081.

[29]

Llamas-Velasco M., Ovejero-Merino E., Fraga J., García-Diez A., Moreno-Balsalobre R. Pemetrexed-induced painful erythematous nodules in both legs in a patient with recurrent mesothelioma. J Cutan Pathol. 2018;45(2):184-6. doi: 10.1111/cup.13081.

[30]

Tuffanelli DL. Lupus erythematosus panniculitis (profundus). Arch Dermatol. 1971;103(3):231-42. doi: 10.1001/archderm.1971.04000150001001.

[31]

Tuffanelli D.L. Lupus erythematosus panniculitis (profundus). Arch Dermatol. 1971;103(3):231-42. doi: 10.1001/archderm.1971.04000150001001.

[32]

Massone C, Kodama K, Salmhofer W, Abe W, Shimizu H, Parodi A, et al. Lupus erythematosus panniculitis (lupus profundus): clinical, histopathological, and molecular analysis of nine cases. J Cutan Pathol. 2005;32(6):396-404. doi: 10.1111/j.0303-6987.2005.00351.x.

[33]

Massone C., Kodama K., Salmhofer W., Abe W., Shimizu H., Parodi A., et al. Lupus erythematosus panniculitis (lupus profundus): clinical, histopathological, and molecular analysis of nine cases. J Cutan Pathol. 2005;32(6):396-404. doi: 10.1111/j.0303-6987.2005.00351.x.

[34]

Winkelmann RK. Panniculitis in connective tissue disease. Arch Dermatol. 1983;119(4):336-44.

[35]

Winkelmann R.K. Panniculitis in connective tissue disease. Arch Dermatol. 1983;119(4):336-44.

[36]

Magro CM, Crowson AN, Kovatich AJ, Burns F. Lupus profundus, indeterminate lymphocytic lobular panniculitis and subcutaneous T-cell lymphoma: a spectrum of subcuticular T-cell lymphoid dyscrasia. J Cutan Pathol. 2001;28(5):235-47. doi: 10.1034/j.1600-0560.2001.028005235.x.

[37]

Magro C.M., Crowson A.N., Kovatich A.J., Burns F. Lupus profundus, indeterminate lymphocytic lobular panniculitis and subcutaneous T-cell lymphoma: a spectrum of subcuticular T-cell lymphoid dyscrasia. J Cutan Pathol. 2001;28(5):235-47. doi: 10.1034/j.1600-0560.2001.028005235.x.

[38]

Belov BS, Egorova ON, Savushkina NM, Karpova YuA, Radenska-Lopovok SG. Panniculita in rheumatological practice. Consilium Medicum. Russian Journal. 2016;18(12):117-22. (in Russian)

[39]

Белов Б.С., Егорова О.Н., Савушкина Н.М., Карпова Ю.А., Раденска-Лоповок С.Г. Панникулиты в ревматологической практике // Consilium Medicum. 2016;18(12):117-22.

[40]

Xinyu Wu, Antonio Subtil, Brittany Craiglow, Kalman Watsky, Asher Marks, Christine Ko. The coexistence of lupus erythematosus panniculitis and subcutaneous panniculitis-like T-cell lymphoma in the same patient. JAAD Case Rep. 2018;4(2):179-84. doi: 10.1016/j.jdcr.2017.08.021.

[41]

Olisova OYu, ed. Skin and Venereal Diseases. Moscow: Practical Medicine; 2015. (in Russian)

[42]

Олисова О.Ю., ред. Кожные и венерические болезни. М.: Практическая медицина; 2015.

[43]

Case series of rare lupus erythematosus panniculitis in children. J Am Acad Dermatol. 2015;72(5):197. doi: 10.1016/j.jaad.2015.02.802.

[44]

White C, Baltazar D, Miller R. Progression of discoid lupus to lupus panniculitis: An unexplained and likely underreported phenomenon. Cureus. 2020;12(8):e9904. doi: 10.7759/cureus.9904.

[45]

White C., Baltazar D., Miller R. Progression of discoid lupus to lupus panniculitis: An unexplained and likely underreported phenomenon. Cureus. 2020;12(8):e9904. doi: 10.7759/cureus.9904.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

186

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/